ITCI - Prakiraan rega marang bathi intracellulartherapies.com
Strategic alliances with clinics and streamlined distribution in the US ensure the accessibility of Caplyta therapy for Intra-Cellular Therapies (ITCI). The forward P/E multiple for Intra-Cellular Therapies (ITCI) demonstrates the impact of regulatory policy on market value, while 29.00 expresses the current value of the metric. The creation of benchmark schizophrenia treatments guarantees stable demand for drugs used in treating chronic disorders for many years.
ITCI (Intra-Cellular): rincian analitis lan laporan miturut indikator
- nilai saham lan prakiraan konsensus rega:
- statistik kapitalisasi pasar:
- statistik nilai buku emiten:
- informasi babagan utang lan solvabilitas:
Rasio Total Utang marang Ekuitas Intra-Cellular Therapies|ITCI - Tanggungan utang jangka dawa marang ekuitas|Utang jangka cendhak marang modal Intra-Cellular Therapies|ITCI - Gunggung utang perusahaan|Utang-utang marang kapitalisasi buku Intra-Cellular Therapies Inc.|ITCI - Utang jangka dawa|Utang jangka cendhak perusahaan Intra-Cellular Therapies|Likuiditas cepet intracellulartherapies.com
- indikator profitabilitas perusahaan lan kelipatan valuasi:
ITCI - Bathi resik perusahaan|Bathi mangsa ngarep Intra-Cellular Therapies|ITCI - Pangali P/E|Rega marang bathi mangsa ngarep Intra-Cellular Therapies|ITCI - Rasio rega marang bathi tumrap wutah|Pangali EV/EBITDA Intra-Cellular Therapies Inc.|ITCI - Bathi operasional EBITDA|Bathi saben saham sajrone rolas wulan pungkasan Intra-Cellular Therapies|ITCI - Bathi saben saham sajroning taun lumaku|Wutah bathi resik saben saham taun-ka-taun sajrone 12 wulan pungkasan intracellulartherapies.com|ITCI - Tambahing bathi saben saham ing taun lumaku|Prakiraan wutah bathi saben saham kanggo taun ngarep Intra-Cellular Therapies
- informasi babagan volume dodolan lan pendapatan:
Analisis fundamental perusahaan:Intra-Cellular Therapies, Inc.
The success of the Intra-Cellular Therapies (ITCI) blockbuster in treating psychiatric disorders and its patent protection allow for the valuation of ITCI through the lens of expected earnings. By analyzing the company's historical forward P/E ratio, an investor can compare the current share price with projected net income, which helps determine the fairness of the market price and the asset's growth potential amidst competition.
Pesaing Intra-Cellular Therapies (ITCI)
Rega marang bathi mangsa ngarep Biogen (BIIB)|Neurocrine - Rasio rega marang bathi mangsa ngarep|Regencell - Prakiraan rega marang bathi|Rasio kapitalisasi marang bathi mangsa ngarep AXSM (Axsome Corp)|ACAD - Rega marang bathi mangsa ngarep|Pangali mangsa ngarep rega marang bathi XENE (xenon-pharma.com)|VKTX: Pangali Forward P/E|Supernus Pharmaceuticals, Inc. (SUPN) - Pangali Forward P/E|Prakiraan rega marang bathi CPRX|DNLI - Pangali forward rega marang bathi|Pangali Forward P/E HRMY|Prakiraan rega marang bathi biohavenpharma.com BHVN|Pangali Forward P/E AMLX (Amylyx Pharmaceuticals, Inc.)|Trevi Therapeutics Inc (TRVI) - Rasio prakiraan rega marang bathi|PRAX - Rega marang bathi mangsa ngarep|AVXL: Rega marang bathi mangsa ngarep|CeriBell, Inc. (CBLL) - Rega marang bathi mangsa ngarep|PRTA (Prothena) - Rega marang bathi mangsa ngarep|Prakiraan rega marang bathi ALEC|Pangali Forward P/E Annexon Biosciences|Rega marang bathi mangsa ngarep Omeros Corporation (OMER)|Rega marang bathi mangsa ngarep NGNE (Neurogene Therapeutics)|Pangali Forward P/E ACIU (AC Immune)|Pangali Forward P/E voyagertherapeutics.com VYGR|NMRA - Rega marang bathi mangsa ngarep|Pangali mangsa ngarep rega marang bathi SCLX (Scilex Holding)|TVGN (Tevogen Bio Holdings, Inc.) - Prakiraan rega marang bathi|Alpha Cognition Inc. - Pangali mangsa ngarep rega marang bathi|Prakiraan rega marang bathi CGTX|IKT (inhibikase.com) - Rasio kapitalisasi marang bathi mangsa ngarep|Pangali Forward P/E SAVA|ASRT (assertiotx.com) - Pangali mangsa ngarep rega marang bathi|Pangali Forward P/E COYA (Coya Therapeutics)|VistaGen Therapeutics, Inc. (VTGN) - Rasio prakiraan rega marang bathi|OVID - Rega marang bathi mangsa ngarep|Pangali mangsa ngarep rega marang bathi ABOS (acumenpharm.com)|CRVO: Pangali Forward P/E|Alterity Therapeutics Limited (ATHE) - Pangali Forward P/E|Rega marang bathi mangsa ngarep Clene Inc|PepGen Corp - Rasio rega marang bathi sing dikarepake|Pangali Forward P/E JUNS|Kapitalisasi marang proyeksi bathi relmada.com|Pangali Forward P/E ANVS (Annovis Bio)|Grace Therapeutics Inc (GRCE) - Rasio prakiraan rega marang bathi|AIFF - Rega marang bathi mangsa ngarep|Kapitalisasi marang proyeksi bathi Klotho Neurosciences Inc KLTO|NRSN: Pangali Forward P/E|RVPH - Kapitalisasi marang proyeksi bathi|Prakiraan rega marang bathi MTVA|NRXS (NeurAxis Inc.) - Rasio kapitalisasi marang bathi mangsa ngarep|Pangali Forward P/E HSDT|Prakiraan rega marang bathi passagebio.com PASG|Pangali Forward P/E NEUP (Neuphoria Therapeutics)|Kapitalisasi marang proyeksi bathi minervaneurosciences.com (NERV)|ATHA - Rega marang bathi mangsa ngarep|ADXN (Addex Therapeutics Ltd.) - Rasio rega marang bathi mangsa ngarep|ALZN: Pangali Forward P/E|Rasio prakiraan rega marang bathi Cyclerion Therapeutics, Inc. (CYCN)|Prakiraan rega marang bathi PTIX|Pangali Forward P/E Pasithea|Rega marang bathi mangsa ngarep Cortigent, Inc. (CRGT)|ATXI (Avenue Therapeutics Inc.) - Pangali mangsa ngarep rega marang bathi|Rega marang bathi mangsa ngarep Brainstorm Cell Therapeutics, Inc. BCLI|Cara Therapeutics Inc (CARA) - Rasio prakiraan rega marang bathi|Chromocell Therapeutics - Pangali Forward P/E|Kapitalisasi marang proyeksi bathi Eliem Therapeutics ELYM|Longboard Pharmaceuticals, Inc. (LBPH) - Rega marang bathi mangsa ngarep|Rasio rega marang bathi mangsa ngarep MRNS|Prakiraan rega marang bathi NKGN|NRBO (NeuroBo Pharma) - Rasio kapitalisasi marang bathi mangsa ngarep|Rega marang bathi mangsa ngarep Sage Therapeutics, Inc. (SAGE)|SNPX (synaptogen.com) - Pangali mangsa ngarep rega marang bathi|Pangali Forward P/E TRVN (Trevena)|Pangali Forward P/E Vigil Neuroscience Inc. VIGL|WENA: Prakiraan rega marang bathi|Pangali forward rega marang bathi Cerevel Corp (CERE)
